Toxicology Comes of Age

Literature Cited

1. Hutchens JO. 1948. The Tox Lab.. Sci. Mon. LXVI:107–12 [Google Scholar]
2. Goldstein A. 1997. A rewarding research pathway.. Annu. Rev. Pharmacol. Toxicol. 37:1–28 [Google Scholar]
3. Nelson SR, Walaszek EJ. 1976. A history of pharmacology at Kansas University.. J. Kansas Med. Soc. LXXVII:339–43 [Google Scholar]
4. Woods LA, Doull J. 1991. GRAS evaluation of flavoring substances by the expert panel of FEMA.. Regul. Toxicol. Pharmacol. 14:48–58 [Google Scholar]
5. Natl. Acad. Sci./Natl. Res. Counc./Comm. Toxicol 1999. Four decades of scientific service: a celebratory colloqium.. Inhal. Toxicol. 11:455–636 [Google Scholar]
6. Cook WA. 1985. History of ACGIH TLV's. In Ann. Am. Conf. Gov. Ind. Hyg 123–9 Cincinnati, OH: ACGIH. 389 pp
7. Bartlett J. 1981. Familiar Quotations 15th and 125th Anniversary Edition, ed. EM Beck. Boston/Toronto: Little Brown
8. Calabrese EJ, Baldwin LA. 1999. Chemical hormesis: its historical foundation as a biological hypothesis.. Toxicol. Pathol. 27:195–216 [Google Scholar]
9. Sagan L. 1993. A brief history and critique of the low dose effects paradigm.. Belle Newsl. 2(2):1–7 [Google Scholar]
10. Rozman KK, Doull J. 1999. Hormesis, regulation, toxicity and risk assessment.. Belle Newsl. 8(1):2–6 [Google Scholar]
11. Koelle GB. 2000. Dedication: the zero tolerance concept.. In Toxicology and Risk Assessment, ed H. Salem, EJ Olajos, pp. vi–ix. Philadelphia: Taylor & Francis
12. Rozman KK, Kerecsen L, Viluksela MK, Osterle D, Deml E. et al. 1996. A toxicologist's view of cancer risk assessment.. Drug Metab. Rev. 28:29–52 [Google Scholar]
13. Risk Commission.; 1997. Risk Asseement and Risk Management in Regulatory Decision Making in U.S. Comm. Risk Assess. Risk Manage. Final Rep., Vol. 2. Washington, DC: GPO #055-000-00568-1 [Google Scholar]
14. Crump K. 1996. The linearized multistage model and the future of quantitative risk assessment.. Hum. Exp. Toxicol. 15:787–98 [Google Scholar]
15. Gaylor DW, Kodell RL, Chen JJ, Krewski D. 1998. A unified approach to risk assessment for cancer and noncancer endpoints based on benchmark doses and uncertainty/safety factors.. Regul. Toxicol. Pharmacol. 29:151–57 [Google Scholar]
16. Gaylor DW, Kodell RL, Chen JJ, Krewski D. 1989. A unified approach to risk characterization.. Inhal. Toxicol. 11:575–78 [Google Scholar]
17. Proposed guidelines for carcinogenic risk assessment.. Environ. Prot. Agency. 1996 Fed. Regist. 61(79):17960–8011 [Google Scholar]
18. Lu FC, Sielkin RL. Assessment of safety/risk of chemicals: inception and evolution of the ADI and dose response modeling procedures.. Toxicol. Lett. 59:5–40 [Google Scholar]
19. Doull J. 1994. Back to basics.. Int. J. Toxicol. 16:185–91 [Google Scholar]
20. Purchase IFH, Auton TR. 1995. Thresholds in chemical carcinogenesis.. Regul. Toxicol. Pharmacol. 22:199–205 [Google Scholar]
21. Rozman KK. 1999. Delayed acute toxicity of 1,2,3,4,6,7,8-heptachloro dibenzo-p-dioxin (HpCDD) after oral administration obeys Haber's rule of inhalation toxicity.. Toxicol. Sci. 49:102–9 [Google Scholar]
22. Rozman KK, Doull J. 2000. Dose and time as variables of toxicity.. Toxicology 144:169–78 [Google Scholar]
23. Rozman KK. 2000. The role of time in toxicity or Haber's ct product.. Toxicology 149:35–42 [Google Scholar]
24. Doull J, Rozman KK. 2000. Using Haber's law to define the margin of exposure.. Toxicology 149:1–2 [Google Scholar]
25. Neal RA. 1996. A career in toxicology.. Annu. Rev. Pharmacol. Toxicol. 36:35–46 [Google Scholar]
26. Neal RA, Doull J. 1995. Commentary: the discipline of toxicology.. Fund. Appl. Toxicol. 24:151–53 [Google Scholar]
27. Scala RA. 1998. Reflections.. Int. J. Toxicol. 18:1–6 [Google Scholar]